Barry Sigal
Pulmonary Disease · Charleston, SCNPI 1316929102
Payments from drug & device makers
Across 553 payments — averaging $2525.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$459K
- Boehringer Ingelheim$204K
- AstraZeneca$195K
- Insmed, Inc.$156K
- GSK$130K
- Shionogi Inc$122K
- plus $131K from 31 others
What the payments were for
- Travel & lodging$48824%
- Food & beverage$1,51173%
- Education$663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 168 | $458,824 |
| Boehringer Ingelheim | 23 | $204,155 |
| AstraZeneca(2 entities) | 15 | $194,930 |
| Insmed, Inc. | 53 | $155,728 |
| GSK | 119 | $129,840 |
| Shionogi Inc | 63 | $122,422 |
| Astrazeneca AB | 4 | $46,367 |
| Hikma Pharmaceuticals USA | 4 | $32,524 |
| Teva Pharmaceuticals USA, Inc. | 10 | $23,758 |
| Redhill Biopharma Inc. | 6 | $6,499 |
| Boehringer Ingelheim France S.a.s. | 35 | $5,700 |
| Chiesi USA, Inc. | 3 | $5,673 |
| AbbVie(2 entities) | 2 | $4,693 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,500 |
| Boehringer Ingelheim International GmbH | 1 | $575 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 9 | $522 |
| La Jolla Pharmaceutical Company | 2 | $246 |
| Viiv Healthcare Company | 1 | $191 |
| CSL Behring | 4 | $66 |
| Grifols USA, LLC | 2 | $62 |
| Gilead | 4 | $53 |
| Novartis | 3 | $50 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 |
| Philips North America LLC | 1 | $40 |
| Pfizer | 3 | $37 |
| Bio Products Laboratory USA, Inc. | 1 | $35 |
| Genentech USA, Inc. | 2 | $28 |
| Covis Pharma GmbH | 2 | $26 |
| Mylan Specialty L.p. | 2 | $26 |
| Sanofi | 1 | $25 |
| United Therapeutics Corporation | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Electromed, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Hospira, Inc. | 1 | $13 |
| Phadia US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GIAPREZA$246
How this compares
$1,396,748 in reported general payments places this provider in the 90th percentile of 192 pulmonary disease providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $12,827 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $6,751 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $780 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $129,840 | $19,57833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 192 pulmonary disease providers in South Carolina.
Other pulmonary disease in Charleston
- Patrick FlumeCharleston$4.6M
- Gerard SilvestriCharleston$1.2M
- Rachana KrishnaCharleston$1M
- John HugginsCharleston$885K
- Timothy WhelanCharleston$885K
- Walter JamesCharleston$109K
- John CoxCharleston$95K
- Denise Gabrielle SeseCharleston$75K
- Lauren SullivanCharleston$57K
- Marc JudsonCharleston$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.